Thema
Journal Article
13
Multicenter Study
8
7S5I7G3JQL
5
Brentuximab vedotin
5
Dexamethasone
5
Allogeneic stem cell transplant
4
Allogeneic transplantation
4
Autologous and allogeneic stem cell transplant
4
Autologous transplant and carfilzomib
4
Brentuximab vedotin salvage treatment
4
Carfilzomib plus lenalidomide and dexamethasone (KRd)
4
F0P408N6V4
4
Hodgkin lymphoma
4
KRd as bridge therapy
4
Lenalidomide
4
Ph’+acute lymphoblastic leukemia
4
Ponatinib
4
Real-life experience
4
Relapsed/refractory Hodgkin lymphoma
4
Relapsed/refractory multiple myeloma
4
4Z8R6ORS6L
2
69G8BD63PP
2
72X6E3J5AR
2
7XL5ISS668
2
Bortezomib
2
Brentuximab Vedotin
2
Case Reports
2
Klinische Studie
2
Immunoconjugates
2
Oligopeptides
2
Research Support, Non-U.S. Gov't
2
Thalidomide
2
carfilzomib
2
4340891KFS
1
4Z63YK6E0E
1
905Z5W3GKH
1
ADAM Proteins
1
ADAMTS13 Protein
1
ADAMTS13 protein, human
1
Antibodies, Monoclonal
1
Antineoplastic Agents
1
Antineoplastic Agents, Immunological
1
Antiviral Agents
1
Boronic Acids
1
Busulfan
1
Carbapenems
1
Chemorefractory
1
D2UX06XLB5
1
EC 2.7.10.2
1
EC 3.4.24.-
1
mehr ...